Analysis of the Glutathione Cycle in Children With Rett Syndrome

Edison Pharmaceuticals

Status: Withdrawn

Conditions: Rett Syndrome

Study type: Observational

Funder types: Industry

Identifiers

NCT02360436

EPITRA-14-001

Details and patient eligibility

About

Analyis of the Glutathione Cycle in Children with Rett Syndrome

Full description

To analyze the levels of glutathione and relevant glutathione metabolites in children with Rett syndrome in an effort to better understand disease pathology and biochemistry.

Sex: All

Ages: 2 to 10 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age between 2 and 10, inclusive
• Genetically-confirmed diagnosis of Rett syndrome with MeCP2 mutation
• No change in dietary supplements in three months prior to the initial blood draw
• No participation in interventional pharmaceutical clinical trials in prior 12 months

Exclusion criteria

• None other than meeting Inclusion criteria